Conditions: Diabetes Mellitus, Type 2 Renal Insufficiency
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 741
Healthy volunteers: no

Brief summary:
This study will investigate the efficacy and safety of the BI 10773 in type 2 diabetic patients with renal impairment in order to provide these data for approval for BI 10773 as an antidiabetic agent by regulatory authorities.

Detailed description:

Arms:
arm 1: BI 10773 tablets once daily arm 2: BI 10773 tablets once daily arm 3: Placebo tablets matching BI 10773

Interventions: intervention 1: BI 10773 intervention 2: Placebo intervention 3: Placebo intervention 4: BI 10773 intervention 5: Placebo intervention 6: Placebo
Intervention descriptions: intervention 1: BI 10773 tablets once daily intervention 2: Placebo tablets identical to BI 10773 low dose intervention 3: Placebo tablets identical to BI 10773 high dose intervention 4: BI 10773 tablets once daily intervention 5: Placebo tablets identical to BI 10773 low dose intervention 6: Placebo tablets identical to BI 10773 high dose

Protocol document: